Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine
Many pathophysiological pathways associated with cardiovascular diseases involve multiple drug targets. This article reviews recent advances in the development of pharmacological compounds capable of simultaneously modulating multiple mechanisms. Multitarget drugs offer a promising therapeutic approach for complex cardiovascular disorders, including ...
Gyuzel Y. Mitronova +3 more
wiley +1 more source
Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmias. [PDF]
Xie D +21 more
europepmc +1 more source
Extracorporeal membrane oxygenation for refractory arrhythmia in a neonate carrying an SCN5A variant: a case report. [PDF]
Yixian C +8 more
europepmc +1 more source
Semaglutide in Atrial Arrhythmias: State of the Art and Future Perspectives. [PDF]
Maggio E +9 more
europepmc +1 more source
Antiarrhythmic drugs and polyneuropathy
A total of 151 patients on chronic treatment with amiodarone and other antiarrhythmic drugs were subjected to standard clinical and electrophysiological investigation to assess the prevalence and specificity of polyneuropathy.
Bellocci, Fulvio, Fenici, Riccardo
core
Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone. [PDF]
Bea S +5 more
europepmc +1 more source
Association of anti-catecholaminergic antiarrhythmic drugs with survival in sepsis-associated new-onset atrial fibrillation. [PDF]
Huang X +4 more
europepmc +1 more source
Comparative Effectiveness of Antiarrhythmic Drugs on Early Atrial Tachyarrhythmias in the Blanking Period After Atrial Fibrillation Catheter Ablation. [PDF]
Kashiwa A +7 more
europepmc +1 more source
Temporary Rhythm Control with Flecainide in Atrial Fibrillation-Related Conversion Pauses Prior to Catheter Ablation: A Case of Successful Pharmacological Bridging. [PDF]
Skakun O +8 more
europepmc +1 more source
Artificial Intelligence for Precision Antiarrhythmic Drug Therapy in Atrial Fibrillation: From Recurrence Prediction to Comparative Treatment Selection. [PDF]
Scridon A, Halațiu VB, Cozac DA.
europepmc +1 more source

